Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOS Attaque Cérébrale is a French non-profit association dedicated to the prevention, treatment, and research of stroke (AVC). Founded in 2001 by Professor Pierre Amarenco, the organization plays a pivotal role in the clinical research landscape, funding and managing major international trials such as the TST (Treat Stroke to Target) trial and the TIAregistry.org. The association provides critical educational resources for patients and healthcare professionals, including the SOS-TIA clinic model which offers 24/7 access to stroke specialists. It operates in close collaboration with academic centers like the Bichat-Claude Bernard Hospital and maintains partnerships with leading pharmaceutical companies to advance stroke care and secondary prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOS Attaque Cérébrale.